Skip to main content
. 2021 Apr 1;9(4):341. doi: 10.3390/vaccines9040341

Figure 1.

Figure 1

PRISMA-P flow diagram for the identification of the Phase III RCTs included in the quantitative analysis concerning the efficacy of COVID-19 vaccines. COVID-19: Coronavirus Disease 2019; PRISMA-P: Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols; RCT: randomized controlled trial.